EP1827476A2 - USE OF BOMBESIN/GASTRIN-RELEASING PEPTIDE ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY CONDITIONS, ACUTE LUNG INJURY AND BIPOLAR DISORDER